II
TNXP icon

Ishara Investments’s Tonix Pharmaceuticals TNXP Stock Holding History

Ishara Investments’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.32M Buy
+338,250
New +$4.36M 3.17% 13

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Ishara Investments's TNXP Position: Q2 2026 in Review

Ishara Investments opened a new position in Tonix Pharmaceuticals (TNXP) in Q2 2026: 338,250 shares worth $4.32M. The stake represents 3.17% of the portfolio and ranks #13 among its holdings.

93 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Ishara Investments held 338,250 shares of Tonix Pharmaceuticals worth $4.32M as of Q2 2026.
  • Tonix Pharmaceuticals was a new Ishara Investments position in Q2 2026.
  • Tonix Pharmaceuticals made up 3.17% of Ishara Investments's portfolio in Q2 2026, its #13 holding.
  • 93 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Ishara Investments's 13F filing for Q2 2026, filed 14 Aug 2026.